I-Mab Biopharma
IMAB
$1.80
Share price
0.28%
Change (1 day)
-47.22%
Change (1 year)
Categories
Earnings for I-Mab Biopharma (IMAB)
Earnings in 2020 (TTM): $78.91 M
According to I-Mab Biopharma's latest financial reports the company's current earnings (TTM) are $78.91 M. In 2022 the company made an earning of -$0.37 B an increase over its 2021 earnings that were of -$0.37 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for I-Mab Biopharma from 2017 to 2020
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 | -$0.37 B | -0.81% |
| 2021 | -$0.37 B | -593.63% |
| 2020 | $74.22 M | -135.78% |
| 2019 | -$0.21 B | 266.31% |
| 2018 | -$56.63 M | 25.9% |
| 2017 | -$44.98 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.19 B | -333.57% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$18.95 M | -124.01% | 🇺🇸 USA |